COVID-19 SARS-CoV-2 Antibody Testing Study
ClinicalTrials.gov; 12/08/2021; TrialID: NCT05009888
Clinical Trial Register
| ICTRP | ID: ictrp-NCT05009888
ABSTRACT
Condition
HealthyPrimary outcome:
Acceptability of performing antibody testing procedures involving a capillary blood sample collected via finger-prick;Test validity of the antibody tests that are performedCriteria
Inclusion Criteria
- King's College Staff member
- Aged 18 years or over
- Able to freely give informed consent
Exclusion Criteria
The participant may not enter the study if ANY of the following apply
- known to have an infectious disease including a current SARS-CoV-2 infection.
- Any significant disease or disorder which, in the opinion of the Investigator, may
either put the participants at risk because of participation in the research study, or
may influence the result of the research study, or the participant's ability to
participate in the research study. Examples of disorders or diseases which would be
excluded include
- Medically diagnosed bleeding disorder;
- Medically diagnosed platelet disorder;
- Anticoagulant medication.
Collection:
Clinical trial registers
Database:
ICTRP
Year:
2021
Document Type:
Clinical Trial Register
Similar
MEDLINE
...
LILACS
LIS